In the latest Weekly Dish, Andrew Sullivan marks a perhaps significant change in how mainstream media outlets are discussing the Trans Movement:
An unusual thing happened in the conversation about transgender identity in America this week. The New York Times conceded that there is, indeed, a debate among medical professionals, transgender people, gays and lesbians and others about medical intervention for pre-pubescent minors who have gender dysphoria. The story pulled some factual punches, but any mildly-fair airing of this debate in the US MSM is a breakthrough of a kind.
Here’s the truth that the NYT was finally forced to acknowledge: “Clinicians are divided” over the role of mental health counseling before making irreversible changes to a child’s body. Among those who are urging more counseling and caution for kids are ground-breaking transgender surgeons. This very public divide was first aired by Abigail Shrier a few months ago on Bari’s Substack, of course, where a trans pioneer in sex-change surgery opined: “It is my considered opinion that due to some of the … I’ll call it just ‘sloppy’, sloppy healthcare work, that we’re going to have more young adults who will regret having gone through this process.” Oof.
The NYT piece also concedes another key fact: that puberty blockers are neither harmless nor totally reversible. Money quote:
Some of the drug regimens bring long-term risks, such as irreversible fertility loss. And in some cases, thought to be quite rare, transgender people later “detransition” to the gender they were assigned at birth. Given these risks, as well as the increasing number of adolescents seeking these treatments, some clinicians say that teens need more psychological assessment than adults do.
I would think that, just as a general rule, minors making permanent, life-changing decisions should receive more psychological treatment than adults. How on earth is this not the default? In what other field of medicine do patients diagnose themselves, and that alone is justification for dramatic, irreversible medication?
The NYT doesn’t give you the data for the “increasing number” of transitions because it’s hard to find in the US. In the UK, however, the data show a 3,200 percent rise in adolescents seeking transition over a decade — 70 percent of whom are girls seeking to become boys, a break from historical norms where boys/men were much more likely to seek transition. Nor does the NYT give any data for “detransitioners”. But any brief look online suggests they are not exactly “quite rare”. They are, in fact, becoming a small but recognizable and tenacious part of the trans landscape. And among the risks of puberty blockers that the NYT does not mention are neurological damage, bone-density loss, and a permanent inability to experience sexual pleasure. And in almost every case (98 percent in one report), puberty blockers are never reversed.
